Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064347 · ClinicalTrials.gov registry record · NA
Targeted Enteral Nutrient Delivery: A Prospective Randomized Study
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03064347: Completed NA study, sponsored by University of Southern California.
NCT03064347 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03064347, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study will evaluate whether enteric-coated nutrients increase some glucose and regulating hormone levels, glucose tolerance and satiety in overweight and obese individuals with type 2 diabetes.
Primary Outcome
Integrated Area under the curve (AUC) levels of blood GLP-1 on meal tolerance tests.
Interventions
- DIETARY_SUPPLEMENT Sucrose plus Whole Milk Powder in Enteric Coating
- DIETARY_SUPPLEMENT Non coated Sucrose plus Whole Milk
- DIETARY_SUPPLEMENT Sucrose in Enteric Coating
- DIETARY_SUPPLEMENT Sucrose with Separate Enteric Coating Materials
- DIETARY_SUPPLEMENT Whey Protein in Enteric Coating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2018-06-20 |
| Phase | NA |
What the finished NCT03064347 record still lists
NCT03064347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Sucrose plus Whole Milk Powder in Enteric Coating is the first listed.
NCT03064347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03064347 about?
NCT03064347 is a clinical study titled "Targeted Enteral Nutrient Delivery: A Prospective Randomized Study". This study will evaluate whether enteric-coated nutrients increase some glucose and regulating hormone levels, glucose tolerance and satiety in overweight and obese individuals with type 2 diabetes.
What is the current status of trial NCT03064347?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2017-02-22. Estimated completion is 2018-06-20.
What interventions are being tested in trial NCT03064347?
The interventions under investigation include: Sucrose plus Whole Milk Powder in Enteric Coating (DIETARY_SUPPLEMENT), Non coated Sucrose plus Whole Milk (DIETARY_SUPPLEMENT), Sucrose in Enteric Coating (DIETARY_SUPPLEMENT), Sucrose with Separate Enteric Coating Materials (DIETARY_SUPPLEMENT), Whey Protein in Enteric Coating (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03064347?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03064347's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI